Parexel on the up as 2Q figures impress
Contract research company Parexel saw its share rocket more than 30 per cent yesterday after it reported a hike in its second quarter revenues and despite a fallback in net profits.
Archives for January 28, 2009
WHO delays “counterfeit” redefinition plan
The WHO has delayed its controversial EB 124/14 amendment that would, according to some groups, broaden the organisation’s definition of “counterfeit” from its current focus on patient health to include infringements of intellectual property.
Medidata plans $86m IPO
eClinical specialist Medidata Solutions has filed to list on the US Nasdaq exchange via an initial public offering that it hopes will raise $86m.
Icon updates MIRA in response to FDA guidance
Icon has brought its operations in line with new FDA guidelines by implementing an electronic system to accelerate the adjudication of cardiovascular events in diabetes trials.
Equateq uses “wizardry” to synthesise DGLA
Equateq is at Informex 2009 showcasing its synthesised 98 per cent pure omega-6 DGLA, use of which has previously been restricted owing to difficulties obtaining it from natural sources.
Track & trace viable today; EU backed pilot study
GS1 UK has released positive preliminary results from a track and trace pilot study, which used bar codes and EPC/RFID tags to follow drugs from manufacturing plants to a hospital.